Yttrium (90Y) tacatuzumab tetraxetanYttrium (90Y) tacatuzumab tetraxetan is an investigational humanized monoclonal antibody intended for the treatment of cancer. The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells. Read from the Drugbox of the Wikipedia article Yttrium (90Y) tacatuzumab tetraxetan, revision 1370568953.

Property

Value

Formula

C6470H9971N1712O2007S4290Y, 281496.76 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.